Cyclist Lance Armstrong, who was stripped of his seven Tour de France titles last autumn after doping officials proved that he used drugs and doping techniques throughout his career, has told associates that he is considering publicly admitting that he used banned performance enhancing drugs an blood transfusions in order to gain a competitive edge.
According to the New York Times, the disgraced cyclist was moving towards confession, and had even been in discussions with the U.S. Anti-Doping Agency (USADA).
Armstrong, 41, met Travis Tygard, the USADA's chief executive, in an effort to mitigate the lifetime ban that he was given for playing a lead role in doping on his Tour de France winning teams.
Armstrong is also currently at the center of a number of legal disputes over his doping. The Sunday Times has sued him for the repayment of a libel settlement that the newspaper was forced to pay him over doping allegations.
Armstrong is hoping to compete in triathalons and various running events, however since those competitions are sanctioned by organizations that adhere to the world anti-doping code, he won't be permitted to participate due to his lifetime ban under the world anti-doping code.